← Evidence map

ReviewCancers2022

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma.

Mu Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2022
2023
2024
2025
2026
2027
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36551694